Reynoso Jamie L. sold $36K of CLOV
Reynoso Jamie L. (CEO, Medicare Advantage) sold 7,289 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.91 on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on executive share activity but does not introduce new operational, regulatory, or financial information about the company.
Market read
A routine, pre-arranged insider sale is disclosed; it may slightly influence sentiment but is unlikely to drive a sustained repricing without additional catalysts.
What to watch
Traders may over-weight small insider sales; the more relevant signal would be large, non-10b5-1 transactions or changes in guidance/regulatory outcomes.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments, Corp. (DE).
Ticker impact
Clover Health CEO Jamie L. Reynoso sold 7,289 shares in an open-market transaction on 2026-06-11 under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any effect should be small and sentiment-driven rather than directional.
The filing is a routine insider sale (10b5-1 pre-arranged) with modest dollar value (~$36K), providing disclosure but not new company fundamentals.
Market effects
No direct sector read-across; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish information.
Key entities
- issuerCLOVER HEALTH INVESTMENTS, CORP. /DE
Company whose shares were sold by an officer under a 10b5-1 plan.
- insiderReynoso Jamie L.
CEO, Medicare Advantage; sold 7,289 shares on 2026-06-11.
- trading mechanism10b5-1 plan
Pre-arranged plan that typically reduces interpretive weight of insider sales.
